Latest Biotech News

A research team demonstrated that encapsulating cisplatin with silibinin inside biodegradable PLGA polymeric nanoparticles improves antitumor efficacy in cervical cancer models compared with free...

A comprehensive review examined the biomedical promise and broader effects of targeted protein degradation (TPD), surveying therapeutic potential, off‑target risks, and ecological considerations....

CMS launched a voluntary payment model designed to expand Medicare coverage for GLP‑1 weight‑loss drugs. The agency invited plans and providers to participate in a pilot that alters payment and...

The FDA approved Omeros’s complement inhibitor Yartemlea to treat a severe, often fatal complication of hematopoietic stem cell transplants. This marks the first approved therapy for the condition...

Johnson & Johnson said an experimental eczema medicine acquired for $1.25 billion failed to meet the company’s efficacy standards and the program will be discontinued. The decision closes a...

Biohaven reported that its potassium‑channel targeted candidate failed a Phase 2 trial in major depressive disorder, marking a second mid‑stage setback for the program. The company said the drug...

Researchers presented an intelligent AAV design framework that programs adeno‑associated viruses to respond to tumor microenvironment cues and activate selectively within malignancies. The...

A team unveiled nanovaccine platforms designed to elicit immune responses against hepatocellular carcinoma (HCC). The nanoparticle formulations target tumor antigens and deliver immune‑stimulatory...

SpatialBench was released as a suite of 146 verifiable spatial‑biology problems drawn from real workflows to evaluate agentic tools in biology. The benchmark spans five platforms (MERFISH, Seeker,...

A landmark study traced exosomal signatures that orchestrate lung‑tropic metastasis, identifying molecular cargo and microenvironment changes that favor colonization. The research used multiomics...

A new review and data synthesis examined the biological reach of targeted protein degradation (TPD) technologies, highlighting therapeutic promise and potential off‑target impacts across organs...

Researchers reported multiple preclinical strategies that overcome lung‑cancer drug resistance, including novel combinations that target epigenetic regulators and metabolic adaptations. Studies...

CMS launched a voluntary payment model aimed at expanding Medicare coverage for GLP‑1 weight‑loss drugs. The agency designed the model to broaden beneficiary access while seeking ways to lower...

The FDA approved Omeros’s complement inhibitor Yartemlea to treat a severe, potentially fatal complication of hematopoietic stem‑cell transplants, marking the first approved therapy for this...

Johnson & Johnson announced it will discontinue development of the experimental eczema drug acquired in a $1.25 billion deal, stating the asset failed to meet the company’s efficacy standards....

Biohaven reported a Phase 2 failure for its potassium‑channel candidate in major depressive disorder, marking the company’s second mid‑stage clinical setback for that program. The company...

Researchers published a Nature Communications study showing engineered vesicles can boost oral antibiotic absorption while protecting the gut microbiome. The team designed vesicles that increase...

Researchers unveiled an intelligent AAV design framework that programs vectors to respond dynamically to tumor‑microenvironment cues, improving targeting and intratumoral penetration. The study...

A Medical Oncology study decoded exosomal molecular signatures that drive tumor tropism to the lung, revealing how tumor‑derived extracellular vesicles condition lung microenvironments to support...

SpatialBench, introduced by computational biology researchers, provides a suite of 146 verifiable problems drawn from authentic spatial‑omics workflows to evaluate agents and models on realistic...